Literature DB >> 24798152

Angiogenic factor thymidine phosphorylase associates with angiogenesis and lymphangiogenesis in the intestinal-type gastric cancer.

Xianglan Zhang1, Zhenlong Zheng, You Keun Shin, Ki-Yeol Kim, Sun Young Rha, Sung Hoon Noh, Hyun Cheol Chung, Hei-Cheul Jeung.   

Abstract

As an angiogenic factor, thymidine phosphorylase (TP) expression in primary tumours has been thought to be a risk factor for lymph node (LN) and hepatic metastasis in patients with gastric adenocarcinoma. However, the molecular basis for the induction of metastasis by TP is largely unknown. We aim to elucidate the role of TP expression in gastric cancer neovascularisation and LN metastasis.The angiogenic and lymphangiogenic activity (CD31, D2-40, Ki-67, VEGFC, VEGFR3) and expression status of TP were detected in 103 resected human gastric carcinoma samples by immunohistochemistry. The influence of TP expression on neovascularisation and cancer cell invasion was further comparatively investigated in two groups of nude mice intraperitoneally injected with TP overexpressing MKN-45 cells (MKN-45/TP) and control cells (MKN-45/CV). In gastric cancer tissues, we found that high TP expression and various angiogenic and lymphangiogenic activities were significantly associated with poor prognostic outcomes. In addition, TP expression was also found to be associated with neovascularisation activity of gastric cancer tissues. In vivo, the MKN-45/TP group exhibited significantly increased infiltrating tumour nodules and neovascularisation activity compared to the MKN-45/CV group. TP could strongly influence gastric cancer progression via the dual activities of angiogenesis and lymphangiogenesis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24798152     DOI: 10.1097/PAT.0000000000000094

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  8 in total

1.  Long-term outcomes after radical gastrectomy in gastric cancer patients with overt bleeding.

Authors:  Lei Wang; Xu-An Wang; Jia-Qi Hao; Li-Na Zhang; Mao-Lan Li; Xiang-Song Wu; Hao Weng; Wen-Jie Lv; Wen-Jie Zhang; Lei Chen; Hong-Gang Xiang; Jian-Hua Lu; Ying-Bin Liu; Ping Dong
Journal:  World J Gastroenterol       Date:  2015-12-21       Impact factor: 5.742

2.  Implication of COPB2 Expression on Cutaneous Squamous Cell Carcinoma Pathogenesis.

Authors:  Taiqin Chen; Ki-Yeol Kim; Yeongjoo Oh; Hei Cheul Jeung; Kee Yang Chung; Mi Ryung Roh; Xianglan Zhang
Journal:  Cancers (Basel)       Date:  2022-04-18       Impact factor: 6.575

Review 3.  TAS-102: a novel antimetabolite for the 21st century.

Authors:  Nataliya Uboha; Howard S Hochster
Journal:  Future Oncol       Date:  2015-11-30       Impact factor: 3.404

Review 4.  Thymidine phosphorylase: A potential new target for treating cardiovascular disease.

Authors:  Wei Li; Hong Yue
Journal:  Trends Cardiovasc Med       Date:  2017-10-20       Impact factor: 6.677

5.  Risk Factors of Microscopically Tumor-Free Surgical Margins for Recurrence and Survival of Oral Squamous Cell Carcinoma Patients.

Authors:  Meiling Pei; Dawool Han; Ki-Yeol Kim; Dong Wook Kim; Woong Nam; Hyung Jun Kim; Eunae Sandra Cho; Hyun Sil Kim; In-Ho Cha; Xianglan Zhang
Journal:  Front Oncol       Date:  2022-07-07       Impact factor: 5.738

6.  Systemic immune-inflammation index, thymidine phosphorylase and survival of localized gastric cancer patients after curative resection.

Authors:  Liu Huang; Shan Liu; Yu Lei; Kun Wang; Min Xu; Yaobing Chen; Bo Liu; Yangyang Chen; Qiang Fu; Peng Zhang; Kai Qin; Yixin Cai; Shengling Fu; Shuwang Ge; Xianglin Yuan
Journal:  Oncotarget       Date:  2016-07-12

7.  Weipixiao attenuate early angiogenesis in rats with gastric precancerous lesions.

Authors:  Jinhao Zeng; Ran Yan; Huafeng Pan; Fengming You; Tiantian Cai; Wei Liu; Chuan Zheng; Ziming Zhao; Daoyin Gong; Longhui Chen; Yi Zhang
Journal:  BMC Complement Altern Med       Date:  2018-09-10       Impact factor: 3.659

8.  AXIN2 and SNAIL expression predict the risk of recurrence in cutaneous squamous cell carcinoma after Mohs micrographic surgery.

Authors:  Guohua Zhao; Ki-Yeol Kim; Zhenlong Zheng; Yeongjoo Oh; Dae San Yoo; Myung Eun Lee; Kee Yang Chung; Mi Ryung Roh; Zhehu Jin
Journal:  Oncol Lett       Date:  2020-01-21       Impact factor: 2.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.